CBD Reduced Binge Drinking in Mice Through an Unexpected Brain Mechanism | Research

The takeaway

CBD dose-dependently reduced binge-like alcohol consumption in mice, and the effect was maintained with repeated dosing, with evidence pointing to a novel receptor mechanism.

Researchers studying alcohol use disorder treatments, anyone interested in CBD therapeutic potential

CBD reduced alcohol intake at every dose tested (7.5-120 mg/kg)

What the researchers found

Acute CBD (7.5-120 mg/kg) dose-dependently reduced binge-like alcohol drinking and blood ethanol levels in mice. The effect was not due to sedation and was maintained across sub-chronic treatment. The well-known serotonin (5-HT1A) and PPARy receptor pathways were ruled out. Instead, the neuropeptide S receptor (NPSR) emerged as a potential mechanism.

Why it matters

Current medications for alcohol use disorder have limited efficacy. CBD's ability to reduce alcohol consumption through a novel receptor mechanism could open new treatment pathways.

The numbers in context

CBD doses: 7.5, 15, 30, 60, 120 mg/kg. Dose-dependent reduction in alcohol intake and blood ethanol concentration. Sub-chronic treatment maintained the effect. 5-HT1A and PPARy blockade had no impact. Subthreshold CBD plus NPSR antagonist reduced drinking.

How the study worked

Researchers used the drinking-in-the-dark mouse model of binge drinking. CBD was tested at multiple doses (7.5-120 mg/kg) in male and female mice. Behavioral pharmacology approaches tested CBD interaction with four receptor targets: 5-HT1A, PPARy, CXCR4, and NPSR.

What this study cannot tell us

Mouse model of binge drinking does not fully capture human alcohol use disorder. High doses used (up to 120 mg/kg) may not translate directly to human dosing. Single study identifying NPSR mechanism needs replication.

How to read the evidence

Preliminary: animal study using a binge drinking model with a novel mechanistic finding requiring replication

When this study was published

Published in 2025 in British Journal of Pharmacology

The bigger picture

If CBD reduces alcohol intake through NPSR rather than the previously suspected serotonin pathway, it suggests the mechanism is more novel than thought. This could lead to new drug development strategies targeting NPSR for alcohol use disorder.

Questions still open

Would these results translate to human clinical trials? What is the optimal CBD dose for reducing alcohol intake? Does NPSR play a role in other substance use disorders?

Common questions

Could CBD help people drink less?

In mice, CBD consistently reduced binge-like alcohol consumption. However, mouse models do not fully replicate human drinking behavior, and clinical trials would be needed before drawing conclusions about human use.

Why did the researchers rule out serotonin?

Previous theories suggested CBD reduces alcohol intake through serotonin 5-HT1A receptors. When researchers blocked these receptors, CBD still reduced drinking, ruling out this pathway and leading them to investigate alternative mechanisms.

Read the original research

Cannabidiol dose dependently reduces alcohol intake in mice via a non-5-HT1A receptor mechanism: Exploration of other potential receptor targets.

British journal of pharmacology, 182(18), 4236-4261

View on PubMed ↗Publisher’s paper ↗

Citation

Badolato, Connie J; Lynch, Erin A; Arnold, Jonathon C; McGregor, Iain S; Bowen, Michael T. (2025). Cannabidiol dose dependently reduces alcohol intake in mice via a non-5-HT1A receptor mechanism: Exploration of other potential receptor targets.. British journal of pharmacology, 182(18), 4236-4261. https://doi.org/10.1111/bph.70070